Home Feedback Search Online Order CATALOG

International 

+32 (0) 16 58 90 45

+32 (0) 16 50 90 45

France

01 43 25 01 50

01 43 25 01 60

Italy

02 36 00 65 93

02 36 00 65 94

Germany

0241 6085 13140

0241 6085 33033


 

 

Product Details: Insulin-like Growth Factor (IGF-I) human (RECOMBINANT)

Basic Information

 


Product ID: GF-050-8
Product Name: Insulin-like Growth Factor (IGF-I) human (RECOMBINANT)
Unit: 500µg
Category: Growth Factors, Cytokines, Receptors and their Antibodies
Subcategory: Growth Factors/Cytokines/Enzymes

 

Product Details

 


Description: Human IGF-I is a potent mitogen for mesenchymally-derived cells. It is composed of 70 amino acid residues, and is 62% homologous with human IGF-II.

Human IGF-I is produced by genetically engineered yeast, and purified by sequential chromatography.

 

Molecular Weight: 7.5 KDa
Biological Activity: The material is active in a receptor-binding assay using a membrane preparation from placenta.

 

Formulation: Lyophilized powder
Purity: Over 95% pure by N-terminal amino acid sequencing, amino acid composition, HPLC analysis, and SDS gel electrophoresis.
Storage Conditions: Store at +4°C. Reconstitution is best in water or buffer near neutral pH. After reconstitution, storage in aliquots at -80°C is recommended.
Stability: Several months, lyophilized or in solution, at pH 6-7 and +4°C.
Temperature: +4°C
References: 1. Modern Concepts of Insulin-Like Growth Factor. Ed. E. Martin Spencer, M.D. (1991). Elsevier Science Publ. (New York).
2 D'Ercole, A.J. (1987) J. Dev. Physiol. 9:481-495
3. Daughaday, W.H. and Rotwein, P. (1989) Endocr. Rev. 10:68-91
 

 

For more information :: Bioxys and Gentaur BVBA :: Av. de l'Armée 68 B4 :: BE-1040 BELGIUM

Email: info@gentaur.com
 

International 

+32 (0) 16 58 90 45

+32 (0) 16 50 90 45

France

01 43 25 01 50

01 43 25 01 60

Italy

02 36 00 65 93

02 36 00 65 94

Germany

0241 6085 13140

0241 6085 33033

Send mail to webmaster with questions or comments about this web site.
Copyright © 2005 Gentaur BVBA
Last modified: feb-07